Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study

This publication has 26 references indexed in Scilit:

• Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: A population-based study
  Atherosclerosis, 2006
• Diagnosis and Management of the Metabolic Syndrome
  Circulation, 2005
• Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial
  European Heart Journal, 2005
• Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
  Circulation, 2004
• Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women
  Archives of internal medicine (1960), 2004
• Metabolic Syndrome and Vascular Disease
  Circulation, 2004
• Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?
  The American Journal of Cardiology, 2004
• Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
  Circulation, 2003
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986